IFNβ secreted by MSCs binds to IFNβ receptors on cancer cells to activate the HLA‐I gene expression, resulting in an increase in HLA‐I molecules on the surface of tumor cells, which become resistant to NK cell‐mediated killing. The gene discussed is IFNB1; the disease is cancer.